Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A10BD09	INCRESYNC	B	Pioglitazone - 30mg, Alogliptin - 25mg		Tablet, film coated	3,897,143 L.L
M01AC01	INFLACAM	G	Piroxicam - 20mg/ml	20mg/ml	Injectable solution	190,826 L.L
B02BD04	IMMUNINE	BioHuman	Plasma coagulation factor IX, human - 600IU	600IU	Injectable lyophilised powder for solution+diluent	20,506,214 L.L
J07CA06	INFANRIX IPV + HIB	B	Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg		Injectable dry powder+suspension	3,014,239 L.L
L04AX06	IMNOVID	B	Pomalidomide - 2mg	2mg	Capsule, hard	407,188,707 L.L
L04AX06	IMNOVID	B	Pomalidomide - 4mg	4mg	Capsule, hard	417,741,356 L.L
L04AX06	IMNOVID	B	Pomalidomide - 4mg	4mg	Capsule, hard	L.L
L01EA05	ICLUSIG	B	Ponatinib - 15mg	15mg	Tablet, film coated	103,555,839 L.L
L01EA05	ICLUSIG	B	Ponatinib - 45mg	45mg	Tablet, film coated	207,092,651 L.L
R03AL02	IPRASAL VEM	G	Salbutamol (sulfate) - 2.5mg/2.5ml, Ipratropium bromide (monohydrate) - 0.5mg/2.5ml		Inhaltion solution with nebuliser	417,935 L.L
D06BA51	IALUGEN PLUS	B	Silver sulfadiazine - 10mg/g, Sodium hyaluronate - 0.5mg/g		Gauze	1,463,444 L.L
D06BA51	IALUGEN PLUS	B	Silver sulfadiazine - 10mg/g, Sodium hyaluronate - 2mg/g		Cream	1,064,323 L.L
C10BA02	INEGY	G	Simvastatin - 20mg, Ezetimibe - 10mg		Tablet	4,452,598 L.L
C10BA02	INEGY	G	Simvastatin - 40mg, Ezetimibe - 10mg		Tablet	4,484,594 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	188,772 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	174,553 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	167,780 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	170,630 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	166,708 L.L
R01AX	ISOTONIC SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Solution	153,582 L.L
N02CC01	IMIGRAN	B	Sumatriptan (succinate) - 100mg	100mg	Tablet, film coated	616,824 L.L
N02CC01	IMIGRAN	B	Sumatriptan (succinate) - 50mg	50mg	Tablet, film coated	378,964 L.L
D05AA	ICHTAMMOL OINTMENT	G	Tars - 10%	10%	Ointment	90,869 L.L
D05AA	ICHTAMMOL OINTMENT	G	Tars - 10%	10%	Ointment	174,060 L.L
C08DA01	ISOPTIN SR	B	Verapamil (HCl) - 240mg	240mg	Tablet, film coated, prolonged release	1,085,822 L.L
C08DA01	ISOPTIN	B	Verapamil (HCl) - 80mg	80mg	Tablet, film coated	382,554 L.L